NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges. NYSE Euronext registered increased trading activity on U.S. cash equities and options exchanges in November and strong year-to-date volume gains across all its global multi-asset platforms.
U.S. cash products average daily volume ("ADV") increased 26% to 4.1 billion shares(1).
-- NYSE listed matched volume (Tape A) increased 14% to 2.6 billion shares and Tape A market share was 42.7%.
-- NYSE Arca and NYSE Alternext US listed matched volume (Tape B) increased 174% to 666 million shares.
-- Nasdaq listed matched volume (Tape C) decreased 4% to 374 million shares.
-- Exchange-traded funds matched volume increased 94% to 672 million shares.
European cash products ADV decreased 4% to 1.5 million transactions(1,2).
-- European cash trading activity qualifying for Pack Epsilon pricing represented 34% of total transactions executed.
European derivatives products (Liffe) ADV decreased 2% to 3.7 million futures and options contracts(1).
-- Total interest rate products ADV decreased 14% to 1.8 million contracts.
-- Total equity products ADV increased 14% to 1.9 million contracts. Bclear, Liffe's trade administration and clearing service, processed 775 thousand contracts per day, an increase of 92%.
U.S. derivatives products (equity options) ADV increased 1% to 2.0 million contracts, driven by the addition of NYSE Amex equity options(1).
Please click here for the Monthly Transaction Activity Data Table.
About NYSE Euronext
NYSE Euronext (NYX) is the world's leading, most liquid and diverse exchange group. It offers a broad and growing array of financial products and services in cash equities, futures, options, exchange-traded products, bonds, market data, and commercial technology solutions, all designed to meet the evolving needs of issuers, investors and financial institutions. Spanning multiple asset classes and six countries, NYSE Euronext's exchanges include the New York Stock Exchange, Liffe, Euronext and NYSE Arca. With more than 6,500 listed issues, more than any other exchange group, trading on NYSE Euronext's equity markets represents more than one-third of the world's cash equities volume. NYSE Euronext also manages the leading European derivatives exchange by value of trading. NYSE Euronext is part of the S&P 500 index and the only exchange operator in the S&P 100 index. For more information, please visit www.nyx.com.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's reference document for 2007 ("document de reference") filed with the French Autorite des Marches Financiers (Registered on May 15, 2008 under No. R. 08-054), 2007 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorite des Marches Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.
(1) All comparisons versus November 2007.
(2) Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction.
NYSE Euronext
Monthly Volume Summary - Cash Products
Average Daily Volume Total Volume Total Volume
(Unaudited) Nov-08 Nov-07 % Chg Nov-08 Nov-07 % Chg YTD 2008 % Chg vs. YTD 2007
Number of Trading Days - European Markets 20 22 20 22 235
Number of Trading Days - U.S. Markets 19 21 19 21 231
European Cash Products (trades in thousands) 1,472 1,526 -3.6% 29,432 33,574 -12.3% 371,841 24.0%
Equities 1,415 1,463 -3.3% 28,300 32,193 -12.1% 359,167 25.0%
Exchange-Traded Funds 13 8 60.5% 266 182 45.9% 2,139 47.3%
Structured Products 39 49 -21.0% 770 1,073 -28.2% 9,313 -3.0%
Bonds 5 6 -16.0% 96 126 -23.6% 1,222 -19.8%
U.S. Cash Products (shares in millions)(2) 4,121 3,284 25.5% 78,300 68,964 13.5% 821,155 22.3%
NYSE Listed (Tape A) Issues (1)
NYSE Group Handled Volume (2) 2,891 2,516 14.9% 54,920 52,835 3.9% 601,610 15.9%
NYSE Group Matched Volume (3) 2,602 2,276 14.3% 49,430 47,797 3.4% 542,297 12.9%
NYSE Group TRF Volume (4) 62 177 -65.2% 1,172 3,722 -68.5% 70,608 420.4%
Total NYSE Listed Consolidated Volume 6,098 4,186 45.7% 115,855 87,909 31.8% 1,183,683 50.3%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 47.4% 60.1% -12.7% 47.4% 60.1% -12.7% 50.8% -15.1%
Matched Volume (3) 42.7% 54.4% -11.7% 42.7% 54.4% -11.7% 45.8% -15.2%
TRF Volume (4) 1.0% 4.2% -3.2% 1.0% 4.2% -3.2% 6.0% 4.2%
NYSE Arca & Alternext US (Tape B) Listed Issues
NYSE Group Handled Volume (2) 779 287 171.7% 14,796 6,019 145.8% 112,051 129.6%
NYSE Group Matched Volume (3) 666 243 174.4% 12,654 5,097 148.3% 97,032 131.1%
NYSE Group TRF Volume (4) 37 60 -37.5% 708 1,252 -43.5% 35,631 638.2%
Total NYSE Arca & Amex Listed Consolidated Volume 2,272 870 161.1% 43,170 18,275 136.2% 336,062 152.9%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 34.3% 32.9% 1.4% 34.3% 32.9% 1.4% 33.3% -3.4%
Matched Volume (3) 29.3% 27.9% 1.4% 29.3% 27.9% 1.4% 28.9% -2.7%
TRF Volume (4) 1.6% 6.9% -5.3% 1.6% 6.9% -5.3% 10.6% 7.0%
Nasdaq Listed (Tape C) Issues
NYSE Group Handled Volume (2) 452 481 -6.2% 8,583 10,110 -15.1% 107,493 3.9%
NYSE Group Matched Volume (3) 374 389 -3.9% 7,108 8,173 -13.0% 90,044 6.9%
NYSE Group TRF Volume (4) 35 174 -79.6% 674 3,649 -81.5% 48,634 111.8%
Total Nasdaq Listed Consolidated Volume 2,278 2,446 -6.9% 43,280 51,367 -15.7% 535,822 5.5%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 19.8% 19.7% 0.1% 19.8% 19.7% 0.1% 20.1% -0.3%
Matched Volume (3) 16.4% 15.9% 0.5% 16.4% 15.9% 0.5% 16.8% 0.2%
TRF Volume (4) 1.6% 7.1% -5.5% 1.6% 7.1% -5.5% 9.1% 4.6%
Exchange-Traded Funds (1,5)
NYSE Group Handled Volume (2) 780 397 96.3% 14,813 8,339 77.6% 117,629 78.1%
NYSE Group Matched Volume (3) 672 347 93.5% 12,765 7,291 75.1% 102,583 74.7%
NYSE Group TRF Volume (4) 40 84 -51.9% 763 1,754 -56.5% 39,246 471.7%
Total ETF Consolidated Volume 2,376 1,119 112.3% 45,151 23,506 92.1% 355,133 119.4%
NYSE Group Share of Total Consolidated Volume
Handled Volume (2) 32.8% 35.5% -2.7% 32.8% 35.5% -2.7% 33.1% -7.7%
Matched Volume (3) 28.3% 31.0% -2.7% 28.3% 31.0% -2.7% 28.9% -7.4%
TRF Volume (4) 1.7% 7.5% -5.8% 1.7% 7.5% -5.8% 11.1% 6.8%
NYSE Euronext
Monthly Volume Summary - Derivatives Products
Average Daily Volume Total Volume Total Volume
(Unaudited; contracts in thousands) Nov-08 Nov-07 % Chg Nov-08 Nov-07 % Chg YTD 2008 % Chg vs. YTD 2007
Number of Trading Days - European Markets 20 22 20 22 235
Number of Trading Days - U.S. Markets 19 21 19 21 231
European Derivatives Products 3,698 3,767 -1.8% 73,966 82,868 -10.7% 989,858 12.2%
Total Interest Rate Products (6) 1,767 2,063 -14.4% 35,340 45,390 -22.1% 529,690 8.7%
Short Term Interest Rate Products 1,646 1,915 -14.1% 32,921 42,141 -21.9% 504,737 9.8%
Medium and Long Term Interest Rate Products 121 148 -18.1% 2,419 3,249 -25.5% 24,953 -9.9%
Total Equity Products (7) 1,888 1,652 14.3% 37,764 36,333 3.9% 447,714 16.9%
Individual Equity Products 1,180 945 24.9% 23,601 20,792 13.5% 286,861 20.5%
Equity Index Products 708 706 0.2% 14,163 15,541 -8.9% 160,853 11.0%
of which Bclear 775 405 91.6% 15,503 8,902 74.2% 175,987 66.4%
Individual Equity Products 648 260 149.6% 12,955 5,710 126.9% 149,405 74.6%
Equity Index Products 127 145 -12.2% 2,548 3,192 -20.2% 26,581 31.7%
Commodity Products 43 52 -17.2% 862 1,145 -24.7% 12,453 6.9%
U.S. Derivatives Products
U.S. Derivatives Products - Equity Options (8)
NYSE Group Options Contracts 1,995 1,966 1.4% 37,897 41,291 -8.2% 425,618 41.9%
Total Consolidated Options Contracts 11,752 13,469 -12.7% 223,292 282,853 -21.1% 3,081,231 29.8%
NYSE Group Share of Total 17.0% 14.6% 17.0% 14.6% 13.8% 1.2%
(1)Includes all volume executed in NYSE Group crossing
sessions.
(2)Represents the total number of shares of equity
securities and ETFs internally matched on the NYSE Group's
exchanges or routed to and executed at an external market center.
NYSE Arca routing includes odd-lots.
(3)Represents the total number of shares of equity
securities and ETFs executed on the NYSE Group's exchanges.
(4)Represents NYSE's volume in FINRA/NYSE Trade Reporting
Facility (TRF).
(5)Data included in previously identified categories.
(6)Data includes currency products.
(7)Includes all trading activities for Bclear,
Euronext.liffe's clearing service for wholesale equity derivatives.
(8)Includes trading in U.S. equity options contracts, not
equity-index options.
Source: NYSE Euronext, Options Clearing Corporation and
Consolidated Tape as reported for equity securities.
US Equities data has been updated for Amex integration for October
2008 forward.
